HNHA is a potent HDAC inhibitor with an IC50 of 100 nM. HNHA arrests the cell cycle at the G1/S phase via p21 induction. HNHA inhibits tumor growth and tumor neovascularization. HNHA may be a potent anti-cancer agent against breast cancer[1].
Molecular Weight:
303.42
Purity:
99.76
CAS Number:
[926908-04-5]
Formula:
C17H21NO2S
Target:
HDAC,HIF/HIF Prolyl-Hydroxylase,MMP
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
